Skip to content

Clinical trials

Major Depressive Disorder trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Country / region: India Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20075
20081
20091
20106
20112
20201
20213
20224
20231
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated5
Recruiting3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
All India Institute of Medical Sciences, Bhubaneswar3
AstraZeneca3
GlaxoSmithKline3
Intra-Cellular Therapies, Inc.3
Otsuka Pharmaceutical Development & Commercialization, Inc.3
Seasons Biotechnology (Taizhou) Co., Ltd.3
H. Lundbeck A/S2
Brainsway1
Government Medical College, Bhavnagar1
Johns Hopkins University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder29
Depressive Disorder5
Mood Disorders2
Schizophrenia2
Bipolar Disorder1
Mental Disorders1
Neurocognitive Disorders1
Psychomotor Disorders1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.